Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Liver Cirrhosis

Free Subscription Articles published in Intern Med Retrieve available abstracts of 16 articles: HTML format

Single Articles

May 2025
1. HIDAKA S, Hashiguchi M, Ijuin S, Muromachi K, et al
   A Case of Heyde Syndrome Complicated by Alcoholic Liver Cirrhosis in which Aortic Valve Stenosis Was Diagnosed due to Gastrointestinal Bleeding.
   Intern Med. 2025 May 22. doi: 10.2169/internalmedicine.5469.
   PubMed     Abstract available
   
   
   
2. ICHIKAWA T, Yamashima M, Yamamichi S, Koike M, et al
   Pemafibrate Reduced Liver Stiffness in Patients with Metabolic Dysfunction-associated Steatotic Liver Disease Complicated with Hyperlipidemia and Liver Fibrosis with a Fibrosis-4 Index Above 1.3.
   Intern Med. 2025;64:1296-1302.
   PubMed     Abstract available
   
   
   April 2025
3. OEDA S, Inoue K, Isoda H, Hirai K, et al
   Survey on Awareness and Implementation Rate of Ultrasound Elastography and Attenuation Imaging.
   Intern Med. 2025;64:1143-1149.
   PubMed     Abstract available
   
   
   March 2025
4. HIRAOKA A, Namisaki T, Nakai M, Hara N, et al
   Relationship between daily physical activity and muscle cramping in elderly liver cirrhosis patients-A multicenter study.
   Intern Med. 2025 Mar 29. doi: 10.2169/internalmedicine.5189.
   PubMed     Abstract available
   
   
   
5. KUSUMI Y, Hasebe T, Hayashi M, Kamikokura Y, et al
   Hepatocellular Carcinoma Arising Adjacent to Antiphospholipid Syndrome-associated Hepatic Infarction in a Non-cirrhotic Liver.
   Intern Med. 2025 Mar 22. doi: 10.2169/internalmedicine.5081.
   PubMed     Abstract available
   
   
   January 2025
6. KURUMAZAKI M, Ogawa N, Kobayashi M, Ikejiri F, et al
   A Case of Severe Hypocalcemia During JAK1/2 Inhibitor Therapy for Myelofibrosis in a Patient with Liver Cirrhosis.
   Intern Med. 2025 Jan 15. doi: 10.2169/internalmedicine.4723.
   PubMed     Abstract available
   
   
   
7. TADOKORO T, Tani J, Sato Y, Yano R, et al
   Decompensated Cirrhosis with Hepatopulmonary Syndrome in a Patient with Interrupted Treatment for Hypopituitarism: A Case Report.
   Intern Med. 2025 Jan 3. doi: 10.2169/internalmedicine.4753.
   PubMed     Abstract available
   
   
   
8. AMANO K, Sano T, Ide T, Nakano D, et al
   The Effect of MAFLD on Hepatocarcinogenesis in HBeAg-negative Patients with Undetectable HBV-DNA under NA Therapy: A Multicenter Study.
   Intern Med. 2025;64:1133-1141.
   PubMed     Abstract available
   
   
   July 2024
9. KAMEZAKI H, Iwanaga T, Maeda T, Senoo J, et al
   A Comparison of the Effects of Alcohol Abstinence and Drinking Habit on the Survival of Patients with Alcohol-related Cirrhosis: A Retrospective Observational Study.
   Intern Med. 2024 Jul 18. doi: 10.2169/internalmedicine.4092.
   PubMed     Abstract available
   
   
   June 2024
10. SUEKI A, Kaya D, Nagamatsu S, Yamamoto C, et al
    A Case of Secondary Growth Hormone Deficiency that Developed into Cirrhosis after Several Years of Interrupted Growth Hormone Replacement Therapy.
    Intern Med. 2024 Jun 27. doi: 10.2169/internalmedicine.3896.
    PubMed     Abstract available
    
    
    April 2024
11. HARA Y, Yanagita T, Ishii K, Nakamura K, et al
    Portal Vein Thrombosis Caused by Miliary Tuberculosis.
    Intern Med. 2024;63:1181-1182.
    PubMed    
    
    
    February 2024
12. HADANO Y
    Use of Blood Culture Bottles in the Diagnosis of Spontaneous Bacterial Peritonitis.
    Intern Med. 2024;63:465.
    PubMed    
    
    
    October 2023
13. MIYAZAWA M, Yanagi M, Chiba T, Kido H, et al
    Post-allogeneic Hematopoietic Stem Cell Transplantation Portal Hypertension Not Associated with Liver Cirrhosis, Veno-occlusive Disease, or Graft-versus-host Disease: A Case Report.
    Intern Med. 2023 Oct 13. doi: 10.2169/internalmedicine.2489.
    PubMed     Abstract available
    
    
    May 2023
14. MITA E, Liu LJ, Shing D, Force L, et al
    Real-world Safety and Effectiveness of 24-week Sofosbuvir and Ribavirin Treatment in Patients Infected with Rare Chronic Hepatitis C Virus Genotypes 3, 4, 5, or 6 in Japan.
    Intern Med. 2023;62:1405-1414.
    PubMed     Abstract available
    
    
    April 2023
15. HAYAKAWA Y, Tamaki N, Nakanishi H, Kurosaki M, et al
    Add-on Therapeutic Effects of Rifaximin on Treatment-resistant Hepatic Encephalopathy.
    Intern Med. 2023;62:973-978.
    PubMed     Abstract available
    
    
    March 2023
16. KAINAGA M, Sasaki T, Kitamura M, Nakayama T, et al
    Inflammatory Myopathy Associated with Anti-mitochondrial Antibody-negative Primary Biliary Cholangitis Diagnosed by a Liver Biopsy.
    Intern Med. 2023;62:797-802.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Cirrhosis is free of charge.